Ingredion Inc. (INGR) Financials Nov 14, 2014, 4:13
Ingredion Inc. (INGR) Financials Nov 14, 2014, 4:13 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Ingredion Inc.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 3.67B 4.37B 6.22B 6.53B 6.33B
Cost of Goods Sold (COGS) incl. D&A 3.15B 3.56B 5.26B 5.34B 5.14B
COGS excluding D&A 3.02B 3.4B 5.05B 5.13B 4.95B
Depreciation & Amortization Expense 130M 155M 211M 211M 194M
Depreciation - - 197M 197M 180M
Amortization of Intangibles - - 14M 14M 14M
Gross Income 520M 811M 957M 1.2B 1.19B
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 247M 370M 543M 556M 534M
Research & Development - - 0 37M 37M
Other SG&A 247M 370M 543M 519M 497M
Other Operating Expense 0 0 0 0 0
Unusual Expense 125M 113M (244M) (9M) -
EBIT after Unusual Expense (125M) (113M) 244M 9M -
Non Operating Income/Expense (1M) 8M 8M 17M (47M)
Non-Operating Interest Income 1M 6M 5M 10M 11M
Equity in Affiliates (Pretax) 0 0 0 0 0
Interest Expense 33M 67M 78M 74M 71M
Gross Interest Expense 40M 70M 83M 80M 75M
Interest Capitalized 7M 3M 5M 6M 4M
Pretax Income 115M 275M 593M 601M 547M
Income Tax 68M 99M 170M 167M 144M
Income Tax - Current Domestic 3M (2M) 11M 4M 8M
Income Tax - Current Foreign 65M 131M 141M 166M 106M
Income Tax - Deferred Domestic (4M) (9M) 13M (3M) 9M
Income Tax - Deferred Foreign 4M (21M) 5M 0 21M
Income Tax Credits 0 0 0 0 0
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) - - - 0 0
Consolidated Net Income 47M 176M 423M 434M 403M
Minority Interest Expense 6M 7M 7M 6M 7M
Net Income 41M 169M 416M 428M 396M
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries 41M 169M 416M 428M 396M
Preferred Dividends 0 0 0 0 0
Net Income Available to Common 41M 169M 416M 428M 396M
EPS (Basic) 0.55 2.24 5.44 5.59 5.14
Basic Shares Outstanding 74.9M 75.6M 76.4M 76.5M 77M
EPS (Diluted) 0.54 2.20 5.32 5.47 5.05
Diluted Shares Outstanding 75.5M 76.8M 78.2M 78.2M 78.3M
EBITDA 403M 596M 625M 850M 848M
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Home Testing: A Game Changer for GI Patients Imagine dragging yourself out of bed, managing gut issues, only to face a grueling trip to a lab. It's the last thing a patient with GI symptoms wants. Enter Getlabs and Genova Diagnostics with a welcome shift: a partnership that promises to bring the lab to your doorstep—literally. The Partnership Expansion Getlabs, the...
Continue Reading
Investing in the Future of Lung Cancer Research Damn, you don't see this kind of commitment every day! LUNGevity Foundation is dropping over a million bucks on the table to swell the ranks of lung cancer researchers. They're not just tossing dollars at established players; they're betting on fresh minds to shake things up in this critical field. Tackling lung cancer isn't...
Continue Reading
An Unexpected Shuffle at the Ad Council Alright, folks, let's talk shop about the recent shake-up in the nonprofit realm. The Ad Council, which has been around longer than some of the giants controlling today's marketing landscapes, just plumped up its Board of Directors with 23 new heavy-hitters. We're talking about leaders from every nook and cranny of the...
Continue Reading
Changing Gears to Navigate Global Connectivity Alright, buckle up because Radius Global Infrastructure, Inc. is making a move that’ll reshape how they play the digital infrastructure game. As of October 28, 2026, they’ve wrapped APWireless into their fold, waving goodbye to separate identities and hello to a unified brand. If you’ve got a finger in the tech pie,...
Continue Reading
Profits Up, Revenues Down Here's a tale for the books—Group 1 Automotive reports their third quarter results of 2026 and it's a bit like swapping a thunderstorm for a hurricane. Net income from continuing operations stomped on last year's figures, clocking in at a hefty $102.9 million compared to a skimpy $13.1 million. But don't let that fool you, their total revenues...
Continue Reading
The Unexpected Slide of Beta Bionics So your wallet took a bruising with this Beta Bionics deal, eh? It’s another one of those wild tales from the stock jungle where everyone watching the NASDAQ:BBNX action got clipped when reality didn't match the company chest-thumping. Glancy Prongay Wolke & Rotter LLP just laid it out—ripping the Band-Aid off what Beta Bionics...
Continue Reading
Weathering the Storm: A New Chapter for Jamaica It's been nearly a year since Hurricane Melissa hit, and Jamaica is proving that it won't be pushed around by nature's whims. The island's tourism industry, once battered, is now showing remarkable resilience. With hotels and villas reopening and shaking off the dust, it's safe to say Jamaica is back on its feet, and it's...
Continue Reading
A Bold Leap for the Digimon Card Game Folks, if you've been tapping your foot waiting for Digimon to fire up a serious digital game, well, here's your moment. BANDAI CO., LTD. is rolling the dice as they launch pre-registration for DIGIMON ALYSION, a digital twist on the classic card game, across 49 countries. It's not just a game; it's a reimagining. They're not just...
Continue Reading
You don’t just wander into the White House and leave unimpressed, not if you're someone who lived it like David Hume Kennerly. Imagine stepping behind those gates and through history's lens, capturing moments few had the privilege to see. Kennerly's debut as the Chief White House Photographer was at a turning point in America, just after the Nixon saga collapsed in...
Continue Reading
Electricity Demand Spurs Grid Innovation The winds of change are blowing across Pennsylvania's power grid. FirstEnergy Transmission's (NYSE:FE) subsidiary, Keystone Appalachian Transmission Company (KATCo), is diving into a significant federally funded project to reinforce grid reliability. With electricity demand on an upward trajectory, Pennsylvania and beyond need...
Continue Reading
Top 5 Most Recently Viewed Articles
Why Investors Look for Dividend Stocks Plenty of investors chase growth across stocks, bonds, ETFs—you name it. But if you’re focused on income, the goal shifts: you want steady cash coming in from investments you can buy and sell without much friction. That cash can come from interest on bonds, dividends from stocks, and other income-paying assets. A dividend is...
Continue Reading
Lightbeam Health Solutions Achieves Prestigious Award Lightbeam Health Solutions, recognized nationwide for its leadership in population health enablement technology, has once again demonstrated its commitment to excellence by winning the Best in KLAS award for Remote Patient Monitoring (RPM). This accolade comes with an impressive satisfaction score of 93.6 out of 100...
Continue Reading
The Rise of Online Casinos: A Gamblers’ Paradise The world of online casinos has undergone a transformation, especially with the recent developments in 2025. Why settle for less when the best real money online casinos are just a click away? These establishments not only offer same-day payouts but have also introduced exciting features that enhance the gaming experience...
Continue Reading
Strategic Investment to Transform Mental Health Services Care Solace, a leading provider of mental health care coordination services tailored for K-12 schools and municipalities, has announced a transformative partnership with Lemnis, a philanthropic venture focused on enhancing educational experiences for all learners. This collaboration marks a significant moment for...
Continue Reading
Key Management Decisions Impacting Activist Campaign In a significant development, former Pfizer Inc (NYSE: PFE) CEO Ian Read and former CFO Frank D’Amelio have announced their decision to step back from the activist campaign led by Starboard Value. This unexpected move has raised questions about the future direction of the campaign and its impact on Pfizer's corporate...
Continue Reading